Research

Positive preliminary results on product to help PN patients with balance

RxFunction, announced positive interim results from its walk2Wellness study on Walkasins, a product designed to help peripheral neuropathy patients with balance issues. The results were presented by Lars Oddsson, PhD, Chief Technology Officer of RxFunction, at the American Congress of Rehabilitation Medicine in November 2019. The research update represented interim data from the first 30 …

Positive preliminary results on product to help PN patients with balance Read More »

Coping with Peripheral Neuropathy

In the Foundation for Peripheral Neuropathy’s March 2019 e-newsletter, Dr. Joseph Breitenstein, a professor of psychology and licensed psychologist at Luther College in Decorah, Iowa, and two of his students, Jimmy Conway and Anna Larson, invited people with peripheral neuropathies to participate in a survey on coping with peripheral neuropathy. The main part of the …

Coping with Peripheral Neuropathy Read More »

peripheral neuropathy treatment

Medical Marijuana for Peripheral Neuropathy

by Jessica Robinson-Papp MD, MS, FAAN Mount Sinai Medical Center, and Sara Dehbashi, MD, Neuromuscular Fellow, Mount Sinai Medical Center Medical marijuana use is becoming more common in the U.S. due to legalization in many states. The U.S. federal government still considers all forms of marijuana illegal, however so far they have mostly not interfered …

Medical Marijuana for Peripheral Neuropathy Read More »

Key Data from FPN Patient Registry Highlighted in Top Medical Journal

In January 2019, a study was published by the Journal of the Peripheral Nervous System on the design and characteristics of patient data collected from the Peripheral Neuropathy Research Registry (PNRR). This is the first ever overall study performed on this Patient Registry and one that truly highlights the importance of this dataset for current …

Key Data from FPN Patient Registry Highlighted in Top Medical Journal Read More »

Gene Therapy Blocks Peripheral Nerve Damage in Mice

In a new study from Washington University School of Medicine in St. Louis, scientists have blocked the destruction of nerve axons in mice, a step toward helping patients with various neurodegenerative disorders, including peripheral neuropathy. The findings of this report, originally reported by Julia Evangelou Strait, can be found below. Nerve axons serve as the …

Gene Therapy Blocks Peripheral Nerve Damage in Mice Read More »

FPN Welcomes Newest Research Partner in Washington University School of Medicine in St. Louis

The Foundation for Peripheral Neuropathy (FPN) continues to build a network of leading neurological consortium partner clinics. Starting in January 2019, FPN is pleased to announce the newest research partner added to its consortium of institutions: Washington University School of Medicine in St. Louis. Washington University will join the other five research sites who work …

FPN Welcomes Newest Research Partner in Washington University School of Medicine in St. Louis Read More »

Stem Cell Treatments: A real hope or false promise?

The Foundation for Peripheral Neuropathy receives many inquiries from patients about stem cell treatments for peripheral neuropathy. An article, ‘Snake Oil’ Stem Cell Clinics Peddle False Hope for High Prices recently appeared in The Medium (www.medium.com) on the rise of stem cell treatments for any number of conditions. Is it a real hope or false …

Stem Cell Treatments: A real hope or false promise? Read More »

IMAGiNe Study on anti-MAG IgM paraprotein-associated peripheral neuropathy expanding in the U.S.

The Foundation for Peripheral Neuropathy (FPN) is pleased to announce a new partnership to further research on anti-MAG IgM paraprotein-associated peripheral neuropathy. FPN will be partnering with the IMAGiNe study, a global research collaborative focusing on anti-MAG and IgM paraprotein-associated peripheral neuropathy. Thanks to a donation from the Atlantic Philanthropies Director/Employee Designated Gift Fund, FPN …

IMAGiNe Study on anti-MAG IgM paraprotein-associated peripheral neuropathy expanding in the U.S. Read More »

Topiramate as a Disease Altering Therapy for Cryptogenic Sensory Peripheral Neuropathy

NeuroNEXT and the National Institute of Neurological Disorders and Stroke (NINDS) are undergoing a double-blind, placebo clinical trial looking at the effectiveness of treating peripheral neuropathy with the FDA-approved drug, topiramate. This is a 96-week placebo-controlled trial of topiramate at a target dose of 100 mg daily (50 mg twice daily) as a potentially disease …

Topiramate as a Disease Altering Therapy for Cryptogenic Sensory Peripheral Neuropathy Read More »

Hereditary and idiopathic neuropathies

New Discovery May Lead to New Approach to Treating Neuropathy Pain

Blocking the Pathway of Neuropathy Pain An international collaboration between Indiana University in Bloomington and the Turku Center for Biotechnology in Finland made early inroads into a new approach to reducing neuropathy pain. The researchers identified the correlation between the formation of a certain protein in the cell (NOS1AP) and the transmission of neurological pain. …

New Discovery May Lead to New Approach to Treating Neuropathy Pain Read More »